Safeguard Scientifics Q1 net loss narrows to $3.5M; in advanced deal talks

SAFEGUARD SCIENTIFICS INC

2023-Q1 EPS reported -$0.22

Net loss $3.5M ($0.22/sh) vs $6.7M loss in Q1 2022; cash $18.8M.
Sold Bright Health interest for $850k; deployed $3.0M to Prognos post-Q1.
Reduced FY2023 deployment expectation to $3.0-4.5M from $4.0-6.0M.
Advanced discussions with single counterparty for strategic transaction; no deal yet.
G&A $1.2M and corporate expenses $0.8M, down 4-6% YoY.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SAFEGUARD SCIENTIFICS INC reported the three months ended March 31, 2023 results: net income Net loss for the three months ended March 31, 2023 was $3.5 million, or $0.22 per share, EPS $0.22 per share. Guidance reaffirmed.

Period: the three months ended March 31, 2023
Net income: Net loss for the three months ended March 31, 2023 was $3.5 million, or $0.22 per share
EPS: $0.22 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Safeguard Scientifics, Inc. (NASDAQ:SFE) (“Safeguard” or the “Company”) today announced financial results for the three months ended March 31, 2023.

View on SEC.gov

22 earnings releases filed in the last 30 days. Browse all earnings releases →

SAFEGUARD SCIENTIFICS INC filing history →

Source: SEC EDGAR

accession 0001437749-23-012573

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.